Kangmei Pharmaceutical Co (SHSE:600518) Other Operating Expense : ¥-116 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Other Operating Expense?

Kangmei Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-116 Mil.

Kangmei Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-131 Mil) to Dec. 2023 (¥-127 Mil) and increased from Dec. 2023 (¥-127 Mil) to Mar. 2024 (¥1 Mil).

Kangmei Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥-16,570 Mil) to Dec. 2022 (¥830 Mil) but then declined from Dec. 2022 (¥830 Mil) to Dec. 2023 (¥-114 Mil).

Kangmei Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Other Operating Expense Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1,087.38

987.74

-16,569.96

829.77

-114.37

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															3.36	140.45	-131.24	-126.95	1.31

Kangmei Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-116 Mil.

Kangmei Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines